M J Panzarella1, A H Naqvi, H E Cohen, T A Damron. 1. Department of Orthopedics, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA. panzarem@upstate.edu
Abstract
OBJECTIVE: To determine the predictive value of gadolinium enhancement on MRI in differentiating atypical lipomatous tumor (ALT)/well-differentiated (WD) liposarcoma from benign fatty tumors. DESIGN: All histologically proven fatty tumors with preoperative gadolinium-enhanced MRI were reviewed. Only those tumors with predominantly fatty signal were included. Sensitivity, specificity, and positive and negative predictive values for both gadolinium enhancement and biopsy as predictors for the final diagnosis of ALT/WD liposarcoma were calculated. PATIENTS: From 129 patients evaluated for fatty tumors between 1994 and 2002, the patient population was narrowed to 32 excised fatty tumors with preoperative gadolinium-enhanced MRI. RESULTS: As a predictor of ALT/WD liposarcoma, the presence of gadolinium enhancement showed 100% sensitivity, 71% specificity, 53% positive predictive value and 100% negative predictive value. Needle or incisional biopsy yielded 57% sensitivity, 100% specificity, 100% positive predictive value and 63% negative predictive value for a diagnosis of ALT/WD liposarcoma. CONCLUSIONS: Gadolinium enhancement of a homogeneous fatty soft tissue tumor is a sensitive screening tool to determine possible diagnosis of ALT/WD liposarcoma. Biopsy, on the other hand, is specific but insensitive.
OBJECTIVE: To determine the predictive value of gadolinium enhancement on MRI in differentiating atypical lipomatous tumor (ALT)/well-differentiated (WD) liposarcoma from benign fatty tumors. DESIGN: All histologically proven fatty tumors with preoperative gadolinium-enhanced MRI were reviewed. Only those tumors with predominantly fatty signal were included. Sensitivity, specificity, and positive and negative predictive values for both gadolinium enhancement and biopsy as predictors for the final diagnosis of ALT/WD liposarcoma were calculated. PATIENTS: From 129 patients evaluated for fatty tumors between 1994 and 2002, the patient population was narrowed to 32 excised fatty tumors with preoperative gadolinium-enhanced MRI. RESULTS: As a predictor of ALT/WD liposarcoma, the presence of gadolinium enhancement showed 100% sensitivity, 71% specificity, 53% positive predictive value and 100% negative predictive value. Needle or incisional biopsy yielded 57% sensitivity, 100% specificity, 100% positive predictive value and 63% negative predictive value for a diagnosis of ALT/WD liposarcoma. CONCLUSIONS:Gadolinium enhancement of a homogeneous fatty soft tissue tumor is a sensitive screening tool to determine possible diagnosis of ALT/WD liposarcoma. Biopsy, on the other hand, is specific but insensitive.
Authors: M Hosono; H Kobayashi; R Fujimoto; Y Kotoura; T Tsuboyama; Y Matsusue; T Nakamura; T Itoh; J Konishi Journal: Skeletal Radiol Date: 1997-03 Impact factor: 2.199
Authors: Elba C Etchebehere; Brian P Hobbs; Denái R Milton; Osama Malawi; Shreyaskumar Patel; Robert S Benjamin; Homer A Macapinlac Journal: Eur J Nucl Med Mol Imaging Date: 2015-12-03 Impact factor: 9.236
Authors: Lorenzo Nardo; Yasser G Abdelhafez; Francesco Acquafredda; Silvia Schirò; Andrew L Wong; Dani Sarohia; Roberto Maroldi; Morgan A Darrow; Michele Guindani; Sonia Lee; Michelle Zhang; Ahmed W Moawad; Khaled M Elsayes; Ramsey D Badawi; Thomas M Link Journal: Skeletal Radiol Date: 2020-01-22 Impact factor: 2.199
Authors: Bárbara Ortiz-Ibáñez; José V Amaya; Francisco Baixauli; Manuel Angulo; Empar Mayordomo-Aranda; Carlos Barrios Journal: World J Surg Oncol Date: 2015-06-25 Impact factor: 2.754
Authors: Jessica Rauh; Alexander Klein; Andrea Baur-Melnyk; Thomas Knösel; Lars Lindner; Falk Roeder; Volkmar Jansson; Hans Roland Dürr Journal: BMC Musculoskelet Disord Date: 2018-05-17 Impact factor: 2.362